Analystreport

Bio-Rad Laboratories (NYSE: BIO) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "sell" rating.

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report